These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cerebral infarction with a single oral dose of phenylpropanolamine. Edwards M; Russo L; Harwood-Nuss A Am J Emerg Med; 1987 Mar; 5(2):163-4. PubMed ID: 3828020 [TBL] [Abstract][Full Text] [Related]
6. Phenylpropanolamine-associated hypertension after the use of "over-the-counter" appetite-suppressant products. McEwen J Med J Aust; 1983 Jul; 2(2):71-3. PubMed ID: 6679050 [TBL] [Abstract][Full Text] [Related]
7. A case of affective psychosis after routine use of proprietary cold remedy containing phenylpropanolamine. Dewsnap P; Libby G Hum Exp Toxicol; 1992 Jul; 11(4):295-6. PubMed ID: 1354981 [No Abstract] [Full Text] [Related]
8. Phenylpropanolamine and the risk of hemorrhagic stroke. Kernan WN; Viscoli CM; Brass LM; Broderick JP; Brott T; Feldmann E; Morgenstern LB; Wilterdink JL; Horwitz RI N Engl J Med; 2000 Dec; 343(25):1826-32. PubMed ID: 11117973 [TBL] [Abstract][Full Text] [Related]
9. Neurological and cardiac events on phenylpropanolamine. Prescrire Int; 1999 Dec; 8(44):181. PubMed ID: 11503819 [TBL] [Abstract][Full Text] [Related]
10. Psychotic episodes associated with the use of common proprietary decongestants. Kane FJ; Green BQ Am J Psychiatry; 1966 Oct; 123(4):484-7. PubMed ID: 4163280 [No Abstract] [Full Text] [Related]
11. Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction. Pilsczek FH; Karcic AA; Freeman I Heart Lung; 2003; 32(2):100-4. PubMed ID: 12734532 [TBL] [Abstract][Full Text] [Related]
12. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations. Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233 [TBL] [Abstract][Full Text] [Related]
13. Hypertensive crisis resulting from an MAO inhibitor and an over-the-counter appetite suppressant. Smookler S; Bermudez AJ Ann Emerg Med; 1982 Sep; 11(9):482-4U. PubMed ID: 7114595 [TBL] [Abstract][Full Text] [Related]
14. Over-the-counter phenylpropanolamine: a possible cause of central retinal vein occlusion. Gilmer G; Swartz M; Teske M; Crandall AS Arch Ophthalmol; 1986 May; 104(5):642. PubMed ID: 3707408 [No Abstract] [Full Text] [Related]
15. Exacerbation of psychosis by phenylpropanolamine. Goodhue A; Bartel RL; Smith NB Am J Psychiatry; 2000 Jun; 157(6):1021-2. PubMed ID: 10831490 [No Abstract] [Full Text] [Related]
16. Neurologic signs and symptoms related to over-the-counter diet pills. Mueller SM; Graham JD; Duggan D Indiana Med; 1985 May; 78(5):388-90. PubMed ID: 3998456 [No Abstract] [Full Text] [Related]